Yod tanqisligi sharoitida yashayotgan bolalar va oʻsmirlarda qalqonsimon bezning morfologik xususiyatlari

Автор: Muratova Shahlo Tohirjonovna

Журнал: Re-health journal.

Рубрика: Морфология

Статья в выпуске: 4 (20), 2023 года.

Бесплатный доступ

Bolalardagi qalqonsimon bez (QB) kasalliklari endokrinologiyaning eng muhim muammosi hisoblanadi. Oʻzbekistonda bolalardagi gipertireoz boʻyicha tadqiqotlar oʻtkazilmagan. Maqsad: tireotoksikoz boʻlgan bolalar va oʻsmirlarda QB xususiyatlari va morfologik tuzilishini aniqlash. Material va usullar: gipertireozi bor boʻlgan 213 ta bola va oʻsmirda umumiy klinik, biokimyoviy, immunologik, instrumental va statistik tadqiqot usullari bilan foydalangan. Natijalar: Greyvs kasalligi (GK) boʻlgan bolalar guruhida 95% hollarda 2 darajali buqoq tashxisi qoʻyilgan, oʻrtacha tireotoksikoz ustunlik qilgan (80%), 20,7% tugunli/koʻp tugunli buqoq, 3,3% ida qalqonsimon bezning differensial saratoni (QBS) aniqlangan. Xulosa: Yod tanqisligi sharoitida yuvenil gipertireoz hollarda 3,3% bolalar va oʻsmirlarda GK differensial QBS bilan birga keladi.

Еще

Gipertireoz, bolalar, oʻsmirlar, qalqonsimon bez, Greyvs kasalligi

Короткий адрес: https://sciup.org/14130703

IDR: 14130703

Список литературы Yod tanqisligi sharoitida yashayotgan bolalar va oʻsmirlarda qalqonsimon bezning morfologik xususiyatlari

  • Исмаилов С.И., Рашитов М.М. Результаты эпидемиологических исследований распространенности йододефицитных заболеваний в Республике Узбекистан // Mezhdunarodnyi Endokrinologicheskii Zhurnal. 2017;13:197-201. doi: 10.22141/2224-0721.13.3.2017.104119.
  • Огрызко Е.В., Шелепова Е.А., Кузнецова В.П. Динамика заболеваемости щитовидной железы среди детей в возрасте 0 – 17 лет в Российской Федерации // Современные проблемы здравоохранения и медицинской статистики. – 2020. – №3. – С.341-356. DOI 10.24411/2312-2935-2020-00076.
  • Al-Qahtani MH, ElYahia SA, AlQahtani AS, AlQahtani AJ, Alamer AA, AlQahtani SM, Yousef AA, Albuali WH, Awary BH, Aldajani AA, Al Ghamdi MA. Thyroid Disorders Spectrum in Pediatric Endocrine Clinic; Seven-Year Experience of a Teaching Hospital in Saudi Arabia. Children. 2023; 10(2):390. https://doi.org/10.3390/children10020390
  • Bayramoğlu E., Elmaogulları S., Sagsak E., Aycan Z.. Evaluation of long-term followup and methimazole therapy outcomes of pediatric Graves’ disease: a single-center experience // J Pediatr Endocrinol Metab. – 2019. - Apr 24;32(4). – Р.341-346. doi: 10.1515/jpem-2018-0495.
  • Bové K.B., Watt T., Vogel A., et al. Anxiety and depression are more prevalent in patients with graves’ disease than in patients with nodular goiter // Eur Thyroid J. – 2014. – Vol.3(3). – Р.173-178. doi:10.1159/000365211.
  • Cheetham T. How to use thionamide anti-thyroid drug in the young- what’s new? // Thyroid Res. – 2021. – Vol.14(1):18. doi:10.1186/s13044-021-00109-x
  • Léger J, Oliver I, Rodrigue D, Lambert AS, Coutant R. Graves’ disease in children. Ann Endocrinol (Paris). 2018 Dec;79(6):647-655. doi: 10.1016/j.ando.2018.08.001
  • Minamitani K, Sato H, Ohye H, Harada S, Arisaka O. Committee on Pharmaceutical Affairs, Japanese Society for Pediatric Endocrinology, and the Pediatric Thyroid Disease Committee, Japan Thyroid Association (Taskforce for the Revision of the Guidelines for the Treatment of Childhood-Onset Graves’ Disease); Guidelines for the treatment of childhoodonset Graves’ disease in Japan, 2016. Clin Pediatr Endocrinol. 2017;26(2):29-62. doi: 10.1297/cpe.26.29
  • Muratova Sh. A case of follicular thyroid cancer in a girl with Graves’ disease // Endocrine Abstracts. Volume 90. Abstract book of 25th European Congress of Endocrinologists, 13–16 May 2023, Istanbul, Turkey. – Poster presentations P.521.
  • Troshina EA. [Elimination of iodine deficiency is a concern for the health of the nation. An excursion into the history, scientific aspects and the current state of the legal regulation of the problem in Russia]. Probl Endokrinol (Mosk). 2022 Jul 27;68(4):4-12. Russian. doi: 10.14341/probl13154. PMID: 36104961; PMCID: PMC9762445
  • UNICEF. Исследование по питанию в Узбекистане. Основные положения. – Ташкент., 2019. – 36с
  • Wong TWC, Wong MYS. Remission in pediatric Graves’ disease treated with antithyroid drug and the risk factors associated with relapse. Ann Pediatr Endocrinol Metab. 2022 Dec;27(4):308-314. doi: 10.6065/apem.2244038.019.
Еще
Статья научная